Abstract
Background: Biventricular endocardial (BIV ENDO) pacing may offer a potential benefit over standard CRT, especially in non-responders however the optimal left ventricular endocardial (LV ENDO) pacing site displays marked inter and intra-patient variability. Identifying and targeting late activating, viable tissue appears important.
Keywords